Chugai Pharmaceutical Posts ¥228.07 IFRS EPS for Nine Months
Photo: TokenPost
Chugai Pharmaceutical Co., Ltd. recorded IFRS basic and diluted earnings per share of ¥228.07 for the nine months ended Sept. 30, 2026. Revenue for the period was ¥1,068.1 billion. The financial statements were dated Oct. 27, 2026. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
